Who are Methylphenidate Oral Product's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Vyvanse, Focalin, DIHYDROCODEINE BITARTRATE, PYRILAMINE, Pyrilamine, PYRILAMINE MALEATE.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/methylphenidate-oral-product.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Methylphenidate Oral Product — Competitive Intelligence Brief

Methylphenidate Oral Product (Methylphenidate Oral Product) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Central nervous system stimulant; sympathomimetic amine. Area: Neurology; Psychiatry.

phase 3 Central nervous system stimulant; sympathomimetic amine Dopamine transporter (DAT); Norepinephrine transporter (NET) Neurology; Psychiatry Small molecule Live · refreshed every 30 min

Target snapshot

Methylphenidate Oral Product (Methylphenidate Oral Product) — Vrije Universiteit Brussel. Methylphenidate blocks the reuptake of dopamine and norepinephrine in the central nervous system, increasing their availability at the synapse.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Methylphenidate Oral Product TARGET	Methylphenidate Oral Product	Vrije Universiteit Brussel	phase 3	Central nervous system stimulant; sympathomimetic amine	Dopamine transporter (DAT); Norepinephrine transporter (NET)
Vyvanse	LISDEXAMFETAMINE	Takeda	marketed	Central Nervous System Stimulant	Sodium-dependent dopamine transporter	2007-01-01
Focalin	DEXMETHYLPHENIDATE	Novartis	marketed	Central Nervous System Stimulant	Sodium-dependent dopamine transporter	2001-01-01
DIHYDROCODEINE BITARTRATE	DIHYDROCODEINE BITARTRATE		marketed	Central Nervous System Stimulant [EPC]		1983-01-01
PYRILAMINE	PYRILAMINE		marketed	Central Nervous System Stimulant [EPC]		1973-01-01
Pyrilamine	mepyramine	Impax Labs	marketed	Central Nervous System Stimulant [EPC]	Histamine H1 receptor	1973-01-01
PYRILAMINE MALEATE	PYRILAMINE MALEATE		marketed	Central Nervous System Stimulant [EPC]		1973-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Central nervous system stimulant; sympathomimetic amine class)

Vrije Universiteit Brussel · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Methylphenidate Oral Product — Competitive Intelligence Brief. https://druglandscape.com/ci/methylphenidate-oral-product. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab